Novartis | Capitalisation Boursière



Market Capitalization Changement Date
AbbVie USD 370.64B 56.62B 2025-03
Alcon AG CHF 41.59B 3.16B 2025-03
Amgen USD 167.51B 27.54B 2025-03
AstraZeneca GBP 174.51B 12.2B 2025-03
Autolus Therapeutics Ltd 412.5M 212.89M 2025-03
Bayer EUR 21.7B 2.69B 2025-03
Biogen USD 20.03B 2.25B 2025-03
Bristol-Myers Squibb USD 124.1B 9.39B 2025-03
Eli Lilly USD 741.66B 8.79B 2025-03
Fresenius EUR 22.2B 3.3B 2025-03
Fresenius Medical Care EUR 13.4B 421.72M 2025-03
Galapagos EUR 1.53B 222.53M 2025-03
Genmab DKK 88.7B 10.08B 2025-03
Gilead Sciences USD 139.68B 24.59B 2025-03
GlaxoSmithKline GBP 60.35B 4.54B 2025-03
GRIFOLS EUR 5.19B 496.47M 2025-03
Hikma Pharmaceutical GBP 4.42B 226.35M 2024-12
J&J USD 396.43B 29.72B 2025-07
Lonza CHF 38.7B 3.28B 2024-12
Merck EUR 55.09B 5.73B 2025-03
Merck USD 225.87B 25.78B 2025-03
Novartis CHF 188.82B 67.36B 2025-07
Novo Nordisk A/S 1.59T 523.44B 2025-03
Orion EUR 7.43B 1.56B 2025-07
Pfizer USD 143.72B 6.63B 2025-03
Philips EUR 21.99B 1.07B 2025-03
Recordati EUR 10.94B 355.51M 2025-03
Regeneron Pharmaceuticals USD 58.9B 10.44B 2025-07
Sanofi EUR 125.84B 7.44B 2025-03
UCB EUR 37.38B 10.41B 2024-12


Novartis Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.